Transplanted bone morphogenetic protein/poly(lactic-co-glycolic acid) delayed-release microcysts combined with rat micromorselized bone and collagen for bone tissue engineering

Journal of International Medical Research

Volumn 37, Issue 4, 2009, Pages 1075-1087

  Ji, Y ^a   Xu, G P ^a   Yan, Jing Long ^a   Pan, S H ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Bone morphogenetic protein 2; Bone tissue engineering; Bone transplantation; Controlled release technology; Growth factors; Microcyst

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; MICROSPHERE; POLYGLACTIN; BMP2 PROTEIN, HUMAN; COLLAGEN; LACTIC ACID; POLYGLYCOLIC ACID; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE GRAFT; BONE MASS; BONE TISSUE; BONE TRANSPLANTATION; CONTROLLED STUDY; ENCAPSULATION; ENZYME ACTIVITY; GLUTEUS MAXIMUS MUSCLE; IMPLANT; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSSIFICATION; POSTOPERATIVE PERIOD; PROCESS OPTIMIZATION; RAT; TISSUE ENGINEERING; ANIMAL; BONE PROSTHESIS; DELAYED RELEASE FORMULATION; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE SUBSTITUTES; BONE TRANSPLANTATION; COLLAGEN; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; HUMANS; LACTIC ACID; OSTEOGENESIS; POLYGLYCOLIC ACID; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TISSUE ENGINEERING;

EID: 70350511412     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700412     Document Type: Article

References (22)

1. Wang XT, Yan JL, Ma S, et al: The fate of donor bone cells in different diameter bone grafts: an experiment study. Zhonghua Yi Xue Za Zhi 2005; 85: 2386-2390 [in Chinese]. (Pubitemid 41288510)
2. Zhou H, Qian J, Wang J, et al: Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo. Biomaterials 2009; 30: 1715-1724.
3. Perri B, Cooper M, Lauryssen C, et al: Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J 2007; 7: 235-239. (Pubitemid 46268849)
4. Tabata Y: Nanomaterials of drug delivery systems for tissue regeneration. Methods Mol Biol 2005; 300: 81-100.
5. Alanay A, Chen C, Lee S, et al: The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion. Spine 2008; 33: 1709-1713.
6. Zhang JX, Chen D, Wang SJ, et al: Optimizing double emulsion process to decrease the burst release of protein from biodegradable polymer microspheres. J Microencapsul 2005; 22: 413-422. (Pubitemid 41581879)
7. Ji Y, Yan J, Xu G: An experimental study on ectopic osteogenesis of autologous micromorselized bone compounded with slow-released rhBMP-2/PLGA microsphere. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2007; 21: 1184-1190 [in Chinese].
8. Isobe M, Yamazaki Y, Mori M, et al: The role of recombinant human bone morphogenetic protein-2 in PLGA capsules at an extraskeletal site of the rat. J Biomed Mater Res 1999; 45: 36-41. (Pubitemid 29068436)
9. Pekkarinen T, Hietalal O, Jamsa T, et al: Gamma irradiation and ethylene oxide in the sterilization of native reindeer bone morphogenetic protein extract. Scand J Surg 2005; 94: 67-70. (Pubitemid 40523877)
10. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
11. Chen S, Zhang ZR, Shi HT, et al: Effect of experimental parameters on the encapsulation of aclarubicin A-loaded PLGA nanoparticles prepared by a double emulsion method. Chin J Antibiot 2005; 30: 338-340 [in Chinese]. (Pubitemid 41176236)
12. Yang YN, Lou L, Liang QZ, et al: Preparation and in vitro release of rifampin microsphere encapsulated in biodegradable polyesters. Chem J Chin Univ 2004; 25: 162-165 [in Chinese].
13. Zolnik BS, Leary PE, Burgess DJ: Elevated temperature accelerated release testing of PLGA microspheres. J Control Release 2006; 112: 293-300.
14. Das GS, Rao GHR, Wilson RF, et al: Controlled delivery of taxol from poly(ethylene glycol)-coated poly(lactic acid) microspheres. J Biomed Mater Res 2001; 55: 96-103. (Pubitemid 32157791)
15. Kligman M, Padgett DE, Vered R, et al: Cortical and cancellous morselized allograft in acetabular revision total hip replacement: minimum 5-year follow-up. J Arthroplasty 2003; 18: 907-913. (Pubitemid 37259695)
16. Pereira GC, Kubiak EN, Levine B, et al: Cavitary acetabular defects treated with morselized cancellous bone graft and cementless cups. Int Orthop 2007; 31: 445-450. (Pubitemid 47101371)
17. Steens W, Loehr JF, Wodtke J, et al: Morselized bone grafting in revision arthroplasty of the knee: a retrospective analysis of 34 reconstructions after 2-9 years. Acta Orthop 2008; 79: 683-688.
18. Judas F, Figueiredo MH, Cabrita AM, et al: Incorporation of impacted morselized bone allografts in rabbits. Transplant Proc 2005; 37: 2802-2804. (Pubitemid 41356661)
19. Baas J, Elmengaard B, Jensen TB, et al: The effect of pretreating morselized allograft bone with rhBMP-2 and/or pamidronate on the fixation of porous Ti and HA-coated implants. Biomaterials 2008; 29: 2915-2922.
20. Gungormus M, Kaya O: Evaluation of the effect of heterologous type I collagen on healing of bone defects. J Oral Maxillofac Surg 2002; 60: 541-545.
21. Takaoka K, Nakahara H, Yoshikawa H, et al: Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clin Orthop Relat Res 1988; 234: 250-254. (Pubitemid 18230950)
22. Murata M, Huang BZ, Shibata T, et al: Bone augmentation by recombinant human BMP-2 and collagen on adult rat parietal bone. Int J Oral Maxillofac Surg 1999; 28: 232-237.